Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,956 | -14,892 | -6,526 | -35,355 | -25,930 |
| Depreciation Amortization | -980 | -491 | -538 | -456 | 174 |
| Accounts payable and accrued liabilities | -930 | 658 | -991 | 26 | -891 |
| Other Working Capital | -4,819 | -3,358 | -2,296 | 1,669 | -89 |
| Other Operating Activity | 6,569 | 3,167 | 2,800 | 6,547 | 5,839 |
| Operating Cash Flow | $-24,116 | $-14,916 | $-7,551 | $-27,569 | $-20,897 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,982 | 82,412 | 92,250 | -90,860 | -38,626 |
| PPE Investments | N/A | N/A | N/A | -100 | -100 |
| Investing Cash Flow | $35,982 | $82,412 | $92,250 | $-90,960 | $-38,726 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30 | N/A | N/A | 75,257 | 75,573 |
| Financing Cash Flow | $30 | $N/A | $N/A | $75,257 | $75,573 |
| Beginning Cash Position | 28,164 | 28,164 | 28,164 | 71,436 | 71,436 |
| End Cash Position | 40,060 | 95,660 | 112,863 | 28,164 | 87,386 |
| Net Cash Flow | $11,896 | $67,496 | $84,699 | $-43,272 | $15,950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,116 | -14,916 | -7,551 | -27,569 | -20,897 |
| Capital Expenditure | N/A | N/A | N/A | -100 | -100 |
| Free Cash Flow | -24,116 | -14,916 | -7,551 | -27,669 | -20,997 |